Stage IVA Uterine Sarcoma Terminated Phase 3 Trials for Pegfilgrastim (DB00019)

IndicationStatusPhase
DBCOND0044376 (Stage IVA Uterine Sarcoma)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01012297Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine LeiomyosarcomaTreatment